CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation

References

• Schoknecht K, David Y, Heinemann U. 2015. The blood–brain barrier—Gatekeeper to neuronal homeostasis: clinical implications in the setting of stroke. Semin Cell Dev Biol. 38:35–42. doi:10.1016/j.semcdb.2014.10.004.
   PubMed Web of Science ®Google Scholar
• Chen T, Dai S-H, Li X, Luo P, Zhu J, Wang Y-H, Fei Z, Jiang X-F. 2018. Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia. Redox Biol. 14:229–236. doi:10.1016/j.redox.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Fraisl P, Aragonés J, Carmeliet P. 2009. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov. 8(2):139. doi:10.1038/nrd2761.
   PubMed Web of Science ®Google Scholar
• Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M, et al. 2010. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol. 299(1):833–843.
   Google Scholar
• Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu D-Z, Feinman R. 2004. Persistent HIF-1α activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharidE. Shock. 22(3):270–277. doi:10.1097/01.shk.0000135256.67441.3f.
   PubMed Web of Science ®Google Scholar
• Proost P, Wuyts A, Conings R, Lenaerts JP, Billiau A, Opdenakker G, Van Damme J. 1993. Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines. Biochemistry. 32(38):10170–10177. doi:10.1021/bi00089a037.
   PubMed Web of Science ®Google Scholar
• Wuyts A, Van Osselaer N, Haelens A, Samson I, Herdewijn P, Ben-Baruch A, Oppenheim JJ, Proost P, Van Damme J. 1997. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry. 36(9):2716–2723. DOI:10.1021/bi961999z.
   PubMed Web of Science ®Google Scholar
• Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, Blanchard J, Caldwell CC, Edwards MJ, Lentsch AB, et al. 2011. CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. Hepatology. 53(1):261–271. DOI:10.1002/hep.24028.
   PubMed Web of Science ®Google Scholar
• Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, Blanchard J, Edwards MJ, Lentsch AB. 2010. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology. 48(4):1213–1223. doi:10.1002/hep.22471.
   Web of Science ®Google Scholar
• Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, et al. 2005. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol. 175(10):6931–6939. DOI:10.4049/jimmunol.175.10.6931.
   PubMed Web of Science ®Google Scholar
• Victoria EC, Ec DBT, Ac DSC, Da SD, de Miranda AS, Da SBL, Sugimoto MA, Sousa LP, de Assis Lima IV, de Oliveira ACP, et al. 2017. Knockdown of C-C chemokine receptor 5 (CCR5) is protective against cerebral ischemia and reperfusion injury. Curr Neurovasc Res. 14:999. doi:10.2174/1567202614666170313113056.
   Web of Science ®Google Scholar
• Baur JA, Ungvari Z, Minor RK, Couteur DGL, Cabo RD. Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov. 2012;11(6):443.
   PubMed Web of Science ®Google Scholar
• Dali‐Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J. 2007. Sirtuins: the “magnificient seven”, function, metabolism and longevity. Ann Med. 39(5):335–345. doi:10.1080/07853890701408194.
   PubMed Web of Science ®Google Scholar
• Park S, Mori R, Shimokawa I. 2013. Do sirtuins promote mammalian longevity?: A Critical review on its relevance to the longevity effect induced by calorie restriction. Mol Cells. 35(6):474–480. doi:10.1007/s10059-013-0130-x.
   PubMed Web of Science ®Google Scholar
• Libert S, Guarente L. 2013. Metabolic and Neuropsychiatric Effects of Calorie Restriction and Sirtuins. Annu Rev Physiol. 75(1):669–684. doi:10.1146/annurev-physiol-030212-183800.
   PubMedGoogle Scholar
• Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J, et al. 2010. Silent Information regulator 1 protects the heart from ischemia/reperfusion. Circulation. 122(21):2170–2182. DOI:10.1161/CIRCULATIONAHA.110.958033.
   PubMed Web of Science ®Google Scholar
• Nadtochiy SM, Redman E, Rahman I, Brookes PS. 2011. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res. 89(3):643. doi:10.1093/cvr/cvq287.
   PubMed Web of Science ®Google Scholar
• Nadtochiy SM, Yao H, Mcburney MW, Gu W, Guarente L, Rahman I, Brookes PS. 2011. SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol. 301(4):H1506. doi:10.1152/ajpheart.00587.2011.
   PubMed Web of Science ®Google Scholar
• Wang XX, Wang XL, Tong MM, Gan L, Chen H, Wu SS, Chen J-X, Li R-L, Wu Y, Zhang H-Y, et al. 2016. SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms. Basic Res Cardiol. 111(2):13. DOI:10.1007/s00395-016-0531-z.
   PubMed Web of Science ®Google Scholar
• Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, et al. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 27(24):8807–8814. DOI:10.1128/MCB.01636-07.
   PubMed Web of Science ®Google Scholar
• Murphy E, Steenbergen C. 2008. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 88(2):581–609. doi:10.1152/physrev.00024.2007.
   PubMed Web of Science ®Google Scholar
• Sack MN. 2011. Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart. Am J Physiol Heart Circ Physiol. 301(6):2191–2197. doi:10.1152/ajpheart.00199.2011.
   PubMed Web of Science ®Google Scholar
• Jin L, Galonek H, Israelian K, Choy W, Morrison M, Xia Y, Wang X, Xu Y, Yang Y, Smith JJ, et al. 2010. Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Pro Sci. 18(3):514–525. DOI:10.1002/pro.50.
   Google Scholar
• Koentges C, Pfeil K, Meyer-Steenbuck M, Lother A, Hoffmann MM, Odening KE, Hein L, Bode C, Bugger H. 2015. Preserved recovery of cardiac function following ischemia–reperfusion in mice lacking SIRT3. Can J Physiol Pharmacol. 94(1):72–80. doi:10.1139/cjpp-2015-0152.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang L, Pu H, Mao L, Hu X, Jiang X, Xu N, Anne Stetler R, Zhang F, Liu X, et al. Rapid endothelial cytoskeletal reorganization enables early blood brain barrier disruption and long-term ischemic/reperfusion brain injury. Nature Communications. 2016;7:10523. doi:10.1038/ncomms10523.
   Google Scholar
• Zhang W, Smith C, Shapiro A, Monette R, Hutcheon B, Stanimirovic D. 1999. Increased expression of bioactive chemokines in human cerebromicrovascular endothelial cells and astrocytes subjected to simulated ischemia in vitro. J.Neuroimmunol. 101(2):148–160. doi:10.1016/S0165-5728(99)00137-X.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang X, Dai Y, Pan K, Deng Y, Meng Y, Xu T. 2019. PPAR-γ promotes p38 MAP kinase-mediated endothelial cell permeability through activating Sirt3. BMC Neurol. 19(1):289. doi:10.1186/s12883-019-1508-y.
   PubMed Web of Science ®Google Scholar
• Hong JY, Kang B, Kim A, Hwang S, Ahn J, Lee S, Kim J, Park J-H, Cheon D-S. 2011. Development of a highly sensitive real-time one step RT-PCR combined complementary locked primer technology and conjugated minor groove binder probe. Virol J. 8(1):330. doi:10.1186/1743-422X-8-330.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25(4):402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Loor G, Schumacker PT. 2008. Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion. Cell Death Different. 15(4):686. doi:10.1038/cdd.2008.13.
   PubMed Web of Science ®Google Scholar
• Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Takahara S, Okuyama A. 2007. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1α. Transplantation. 83(10):1371–1379. doi:10.1097/01.tp.0000264200.38926.70.
   PubMed Web of Science ®Google Scholar
• Du F, Zhu L, Qian Z-M, Wu X-M, Yung W-H KY. 2010. Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. BBA. 1802(11):1048–1053. doi:10.1016/j.bbadis.2010.06.013.
   PubMed Web of Science ®Google Scholar
• Granger DN, Sennett M, Mcelearney P, Taylor AE. 1980. Effect of local arterial hypotension on cat intestinal capillary permeability. Gastroenterology. 79(3):474–480. doi:10.1016/0016-5085(80)90372-8.
   PubMed Web of Science ®Google Scholar
• Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor ENE, Timmers L, van Rijen HV, Doevendans PA, Pasterkamp G, et al. 2013. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10(3):301–312. DOI:10.1016/j.scr.2013.01.002.
   PubMed Web of Science ®Google Scholar
• Accili D, Arden KC. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117(4):421–426. doi:10.1016/S0092-8674(04)00452-0.
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME, et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96(6):857–868. DOI:10.1016/S0092-8674(00)80595-4.
   PubMed Web of Science ®Google Scholar
• Ginks WR, Sybers HD, Maroko PR, Covell JW, Sobel BE, Ross J. 1972. Coronary artery reperfusion. J Clin Invest. 51(10):2717–2723. doi:10.1172/JCI107091.
   PubMed Web of Science ®Google Scholar
• Haimovici H. Muscular, renal, and metabolic complications of acute arterial occlusions: myonephropathic-metabolic syndrome. Surgery. 1979;85(4):461.
   PubMed Web of Science ®Google Scholar
• Tian H, Huang P, Zhao Z, Tang W, Xia J. 2014. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression. Cell Physiol Biochem. 34(5):1536–1546. doi:10.1159/000366357.
   PubMedGoogle Scholar
• Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, Gijsbers K, Gouwy M, Proost P, Damme JV. 2004. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Biochem Pharmacol. 68(10):1947–1955. doi:10.1016/j.bcp.2004.07.003.
   PubMed Web of Science ®Google Scholar
• Downward J. 2004. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol. 15(2):177–182. doi:10.1016/j.semcdb.2004.01.002.
   PubMed Web of Science ®Google Scholar
• Li D, Qu Y, Mao M, Zhang X, Li J, Ferriero D, Mu D. 2009. Involvement of the PTEN–AKT–FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia–ischemia. J Cerebral Blood Flow Meta. 29(12):1903–1913. doi:10.1038/jcbfm.2009.102.
   PubMed Web of Science ®Google Scholar
• Wu Y, Peng H, Cui M, Whitney NP, Huang Y, Zheng JC. 2010. CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem. 109(4):1157–1167. doi:10.1111/j.1471-4159.2009.06043.x.
   Web of Science ®Google Scholar
• Van Itallie C, Rahner C, Anderson JM. 2001. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 107(10):1319–1327. doi:10.1172/JCI12464.
   PubMed Web of Science ®Google Scholar
• Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. 1993. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 123(6):1777. doi:10.1083/jcb.123.6.1777.
   PubMed Web of Science ®Google Scholar
• González-Mariscal L, Betanzos A, Nava P, Jaramillo BE. 2003. Tight junction proteins. Prog Biophys Mol Biol. 81(1):1–44. doi:10.1016/S0079-6107(02)00037-8.
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. 2003. Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 4(3):225–236. doi:10.1038/nrm1055.
   PubMed Web of Science ®Google Scholar
• Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. 2008. Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier. J Physiol. 586(7):1937–1949. doi:10.1113/jphysiol.2007.146852.
   PubMed Web of Science ®Google Scholar
• Weksler B, Subileau E, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire‐Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. 2005. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J. 19(13):1872–1874. DOI:10.1096/fj.04-3458fje.
   PubMed Web of Science ®Google Scholar
• Stins MF, Badger J, Kim KS. 2001. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathog. 30(1):19–28. doi:10.1006/mpat.2000.0406.
   PubMed Web of Science ®Google Scholar